Cholangioblastic Intrahepatic Cholangiocarcinoma: A Rare Case of an Inhibin-Positive Variant Mimicking Neuroendocrine TumorsSeptember 12, 2024Oncology
Variation in Cardiovascular Risk Assessment Status in Patients Receiving Oral Anti-Cancer Therapies: A Focus on Equity throughout VISN (Veteran Integrated Service Network) 12September 11, 2024Oncology
Implementing a Prospective Surveillance Physical Therapy Program for Those Affected by CancerSeptember 11, 2024Prostate CancerOncology
Developing a Cancer Rehabilitation Program—Improving Access to Ancillary Services to Mitigate the Impact of Cancer and its Treatments for Veterans Diagnosed With CancerSeptember 11, 2024Oncology
Whole Health Oncology—Just Do It: Making Whole Person Cancer Care Routine and Regular at the Dayton VA Medical Center (DVAMC)September 11, 2024Prostate CancerOncologyBreast Cancer
Neuroendocrine Tumor of Ampulla of Vater: A Rare Case Report and Review of LiteratureSeptember 11, 2024Oncology
“It Takes a Village”: Benefits and Challenges of Navigating Cancer Care with the Pacific Community and the Veterans Health AdministrationSeptember 10, 2024Oncology
Preleukemic Chronic Myeloid Leukemia: A Case Report and Literature ReviewSeptember 10, 2024OncologyLeukemia, Myelodysplasia, Transplantation
Influence of Patient Demographics and Facility Type on Overall Survival in Sezary SyndromeSeptember 10, 2024OncologyLymphoma & Plasma Cell Disorders
RVD With Weekly Bortezomib Has a Favorable Toxicity and Effectiveness Profile in a Large Cohort of US Veterans With Multiple MyelomaSeptember 10, 2024OncologyMultiple Myeloma
Male Patient With a History of Monoclonal B Cell Lymphocytosis Presenting with Breast Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Case Report and Literature ReviewSeptember 10, 2024OncologyLymphoma & Plasma Cell Disorders
